Technology
lungDx Technology and ILD: White Paper
“Improperly treated ILD is associated with a poorer quality of life, an increased risk of life-threatening complications and early mortality.” This white paper provides a comprehensive overview of the pathogenesis of interstitial, its diagnosis and monitoring, and available treatment o...
How to have a challenging conversation as a Line Manager
Donna Stevenson speaks with Neurodiversity & Disability Specialist, Coach Supervisor and Assessor Mark Woodward, about some of the challenges faced by Line Managers when the topic of neurodiversity comes up. ...
High-tech tool could change eye treatment worldwide
Addenbrooke’s eye specialists have developed a new high-tech tool that could change the way glaucoma patients are treated worldwide. ...
Prism advise on sale of health screening software developers
Prism Corporate Broking are pleased to announce that our team have advised on the sale of health screening workflow software developers, Thomson Screening Solutions Ltd, to healthcare platform CCube Solutions which is backed by software-focused investors, Tern Capital. ...
Ground-breaking study proves AI-driven programme has comparable effectiveness to human-delivered care while using up to 8 times fewer therapist hours
A new study by ieso Digital Health in collaboration with the and NIHR BioResource reveals that its AI-driven digital programme delivered results comparable to traditional human-led therapy for generalised anxiety. An estimated 1.2 million people in the UK are on waiting lists for NHS me...
Dylan shares his inspiring story on how all families can be part of research
Dylan reveals how he had major open heart surgery at just 7 years old. He joined the D-CYPHR programme and became a DNA hero to inspire others. ...
Researchers identify a genetic cause of intellectual disability affecting tens of thousands
Novel study links genetic changes in a non-coding gene called RNU4-2 to neurodevelopmental disorders ...
Over 20,000 people join search for new dementia treatments
Volunteers at the BioResource have contributed to a study that aims to speed up the development of much-needed dementia drugs. Our Genes & Cognition cohort will enable scientists in universities and industry to involve healthy individuals in clinical trials to test whether new drugs...
Young heroes from The Regis School help transform children’s health research
In collaboration with our partners at leading mental health charity Anna Freud, D-CYPHR held a learning event at the West Sussex secondary school, listening to pupils’ ideas around children’s rights to good health and highlighting different ways they can make a positive impact. ...
GLAD Study opens recruitment for participants without history of mental health condition
The Genetic Links to Anxiety and Depression (GLAD) Study, part of our Mental Health BioResource, is thrilled to announce the launch of a recruitment drive for individuals without a history of anxiety and depression. In a world where millions are affected by mental health struggles like ...